We are live on ! Find out more
GNMX

Aevi Genomic Medicine Inc
GNMX

Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

22 hedge funds and large institutions have $7.43M invested in Aevi Genomic Medicine Inc in 2013 Q2 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
1
Legal & General Group
United Kingdom
$2.83M +$2.97M +725,000 New
SM
2
Sabby Management
Florida
$1.63M +$1.75M +427,684 New
PA
3
Perceptive Advisors
New York
$570K +$615K +150,000 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$477K +$515K +125,584 New
BIT
5
BlackRock Institutional Trust
California
$367K +$396K +96,597 New
CA
6
Commerzbank Aktiengesellschaft
Germany
$317K +$341K +83,313 New
LPL Financial
7
LPL Financial
California
$255K +$275K +67,186 New
BCM
8
Bridgeway Capital Management
Texas
$207K +$223K +54,400 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$147K +$159K +38,684 New
CD
10
Carl Domino
Florida
$114K +$123K +29,978 New
BFA
11
BlackRock Fund Advisors
California
$97K +$104K +25,455 New
Baillie Gifford & Co
12
Baillie Gifford & Co
United Kingdom
$87K +$93.7K +22,855 New
WPC
13
White Pine Capital
Minnesota
$76K +$82K +20,000 New
HighTower Advisors
14
HighTower Advisors
Illinois
$67K +$72.1K +17,600 New
Northern Trust
15
Northern Trust
Illinois
$59K +$63.7K +15,537 New
Renaissance Technologies
16
Renaissance Technologies
New York
$58K +$62.7K +15,300 New
CDH
17
Charles D. Hyman
$55K +$59.4K +14,500 New
Citigroup
18
Citigroup
New York
$14K +$14.6K +3,573 New
TWA
19
TCI Wealth Advisors
Arizona
$4K +$4.1K +1,000 New
Deutsche Bank
20
Deutsche Bank
Germany
$3K +$3.28K +800 New
TRCT
21
Tower Research Capital (TRC)
New York
– +$410 +100 New
Bank of America
22
Bank of America
North Carolina
– +$443 +108 New

GNMX Hedge Fund Activity: Q2 2013 in Review

22 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Aevi Genomic Medicine Inc (GNMX) for Q2 2013, worth a combined $7.43M.

Buyers outnumbered sellers: 22 funds opened new GNMX positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

  • 22 institutional investors held Aevi Genomic Medicine Inc (GNMX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.43M of Aevi Genomic Medicine Inc stock for Q2 2013.
  • 22 funds opened new Aevi Genomic Medicine Inc positions in Q2 2013 and 0 closed out, a net change of +22 holders.

Based on aggregated 13F filings for Q2 2013.